The antibacterial medicine use in Türkiye shows a steady decline from 2024 to 2028. In 2023, the value stood at 31.3 Units (Defined Daily Dosage) per thousand persons per day. From 2024, the forecasted values are 31.0, 30.7, 30.4, 30.0, and 29.7 respectively. The year-on-year variation shows a decline:
- 2024-2025: -0.97%
- 2025-2026: -0.98%
- 2026-2027: -1.32%
- 2027-2028: -1.00%
The compound annual growth rate (CAGR) over the last five years is -1.01%, indicating a consistent reduction in antibacterial medicine use.
Future trends to watch for include advancements in public health initiatives to reduce unnecessary antibiotic use, greater adherence to prescriptions, and potential impacts from antimicrobial stewardship programs. It's essential to monitor any resistance patterns that could alter current usage trends.
